Bruno Becker

Moelndal, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Correction: CSF p-tau205: a biomarker of tau pathology in Alzheimer's disease.

Correction: CSF p-tau205: a biomarker of tau pathology in Alzheimer's disease.

Journal: Acta neuropathologica

Published: April 21, 2025

Novel insights into the molecular nature of neurofilament light polypeptide species in cerebrospinal fluid.

Novel insights into the molecular nature of neurofilament light polypeptide species in cerebrospinal fluid.

Journal: Brain communications

Published: June 28, 2024

Tau protein profiling in tauopathies: a human brain study.

Tau protein profiling in tauopathies: a human brain study.

Journal: Molecular neurodegeneration

Published: December 20, 2023

CSF p-tau205: a biomarker of tau pathology in Alzheimer's disease.

CSF p-tau205: a biomarker of tau pathology in Alzheimer's disease.

Journal: Acta neuropathologica

Published: August 16, 2023

Novel ultrasensitive immunoassay for the selective quantification of tau oligomers and related soluble aggregates.

Novel ultrasensitive immunoassay for the selective quantification of tau oligomers and related soluble aggregates.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: July 05, 2023

Neurofilament light oligomers in neurodegenerative diseases: quantification by homogeneous immunoassay in cerebrospinal fluid.

Neurofilament light oligomers in neurodegenerative diseases: quantification by homogeneous immunoassay in cerebrospinal fluid.

Journal: BMJ neurology open

Published: February 11, 2023

SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's disease.

SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: October 27, 2022

Quantification of the trans-synaptic partners neurexin-neuroligin in CSF of neurodegenerative diseases by parallel reaction monitoring mass spectrometry.

Quantification of the trans-synaptic partners neurexin-neuroligin in CSF of neurodegenerative diseases by parallel reaction monitoring mass spectrometry.

Journal: EBioMedicine

Published: August 31, 2021

Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers.

Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers.

Journal: Acta neuropathologica communications

Published: November 02, 2020

Extensive Plasmid Library to Prepare Tau Protein Variants and Study Their Functional Biochemistry.

Extensive Plasmid Library to Prepare Tau Protein Variants and Study Their Functional Biochemistry.

Journal: ACS chemical neuroscience

Published: August 25, 2020

Fluid Biomarkers for Synaptic Dysfunction and Loss.

Fluid Biomarkers for Synaptic Dysfunction and Loss.

Journal: Biomarker insights

Published: June 05, 2020

Tauopathy-Associated Tau Fragment Ending at Amino Acid 224 Is Generated by Calpain-2 Cleavage.

Tauopathy-Associated Tau Fragment Ending at Amino Acid 224 Is Generated by Calpain-2 Cleavage.

Journal: Journal of Alzheimer's disease : JAD

Published: March 08, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026